DCCPS Grants Awarded in Response to an NIH RFA Initiative
Initiative: Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)
Fiscal Year: 2017
Total Grants: 4 Total Dollars: $1,165,154
PI Name | Organization Name | Project Title (Click for Abstract, Pubs, etc.) |
Grant Number | Abstract Page URL |
---|---|---|---|---|
Rappaport, Stephen Morris | University of California Berkeley | Using Adductomics to Characterize Exposures to Carcinogens | 5R33CA191159-03 | https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9321944&term=CA191159 |
Salipante, Stephen J | University of Washington | Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations | 3R33CA192980-03S1 | https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9515203&term=CA192980 |
Salipante, Stephen J | University of Washington | Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations | 5R33CA192980-03 | https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9269176&term=CA192980 |
Yeakley, Joanne Mulligan | Biospyder Technologies, Inc. | RASL-Seq Expression Profiling of FFPE Tissues | 5R33CA183688-03 | https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9331515&term=CA183688 |